Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Chang

Showing results (1051-1060 of 1,110) with videos related to

Pageof 111
Sort By:
Scientific Reports|June 8, 2021
Effective inactivated influenza vaccine for the elderly using a single-stranded RNA-based adjuvantYoo-Jin Bang, So-Hee Hong, Hyo-Jung Park, et al.
Physical Review Letters|July 16, 2022
Novel Valence Transition in Elemental Metal Europium around 80 GPaBijuan Chen, Mingfeng Tian, Jurong Zhang, et al.
Drug Testing and Analysis|March 15, 2024
Synthesis, structural characterization, analytical profiling, and application to authentic samples of synthesized Phase I metabolites of the synthetic cannabinoid 5F-MDMB-PICARui-Jia Chen, Zi-Hua Zhang, Shenglan Yang, et al.
JCI Insight|January 6, 2022
Donor NKG2C homozygosity contributes to CMV clearance after haploidentical transplantationXing-Xing Yu, Qian-Nan Shang, Xue-Fei Liu, et al.
Cytometry. Part B, Clinical Cytometry|August 20, 2019
The Quantification of Minimal Residual Disease Pre- and Post-Unmanipulated Haploidentical Allograft by Multiparameter Flow Cytometry in Pediatric Acute Lymphoblastic LeukemiaXin-Yu Wang, Qiao-Zhen Fan, Lan-Ping Xu, et al.
Chinese Medical Journal|December 5, 2018
Association of Persistent Minimal Residual Disease with Poor Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell TransplantationJing Liu, Xiao-Su Zhao, Yan-Rong Liu, et al.
American Journal of Hematology|January 26, 2019
Minimal residual disease status determined by multiparametric flow cytometry pretransplantation predicts the outcome of patients with ALL receiving unmanipulated haploidentical allograftsXiao-Su Zhao, Yan-Rong Liu, Lan-Ping Xu, et al.
Frontiers in Oncology|April 8, 2020
Different Effects of Pre-transplantation Measurable Residual Disease on Outcomes According to Transplant Modality in Patients With Philadelphia Chromosome Positive ALLSi-Qi Li, Qiao-Zhen Fan, Lan-Ping Xu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 28, 2020
Frequency, Risk Factors, and Outcome of Active Tuberculosis following Allogeneic Hematopoietic Stem Cell TransplantationQiao-Zhu Zeng, Yuan-Yuan Zhang, Ye-Jun Wu, et al.
Current Medical Science|June 29, 2021
Predictive Value of Dynamic Peri-Transplantation MRD Assessed By MFC Either Alone or in Combination with Other Variables for Outcomes of Patients with T-Cell Acute Lymphoblastic LeukemiaZhi-Dong Wang, Yue-Wen Wang, Lan-Ping Xu, et al.
Pageof 111

Showing results (1051-1060 of 1,110) with videos related to

Sort By:
Pageof 111
Scientific Reports|June 8, 2021
Effective inactivated influenza vaccine for the elderly using a single-stranded RNA-based adjuvantYoo-Jin Bang, So-Hee Hong, Hyo-Jung Park, et al.
Physical Review Letters|July 16, 2022
Novel Valence Transition in Elemental Metal Europium around 80 GPaBijuan Chen, Mingfeng Tian, Jurong Zhang, et al.
Drug Testing and Analysis|March 15, 2024
Synthesis, structural characterization, analytical profiling, and application to authentic samples of synthesized Phase I metabolites of the synthetic cannabinoid 5F-MDMB-PICARui-Jia Chen, Zi-Hua Zhang, Shenglan Yang, et al.
JCI Insight|January 6, 2022
Donor NKG2C homozygosity contributes to CMV clearance after haploidentical transplantationXing-Xing Yu, Qian-Nan Shang, Xue-Fei Liu, et al.
Cytometry. Part B, Clinical Cytometry|August 20, 2019
The Quantification of Minimal Residual Disease Pre- and Post-Unmanipulated Haploidentical Allograft by Multiparameter Flow Cytometry in Pediatric Acute Lymphoblastic LeukemiaXin-Yu Wang, Qiao-Zhen Fan, Lan-Ping Xu, et al.
Chinese Medical Journal|December 5, 2018
Association of Persistent Minimal Residual Disease with Poor Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell TransplantationJing Liu, Xiao-Su Zhao, Yan-Rong Liu, et al.
American Journal of Hematology|January 26, 2019
Minimal residual disease status determined by multiparametric flow cytometry pretransplantation predicts the outcome of patients with ALL receiving unmanipulated haploidentical allograftsXiao-Su Zhao, Yan-Rong Liu, Lan-Ping Xu, et al.
Frontiers in Oncology|April 8, 2020
Different Effects of Pre-transplantation Measurable Residual Disease on Outcomes According to Transplant Modality in Patients With Philadelphia Chromosome Positive ALLSi-Qi Li, Qiao-Zhen Fan, Lan-Ping Xu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 28, 2020
Frequency, Risk Factors, and Outcome of Active Tuberculosis following Allogeneic Hematopoietic Stem Cell TransplantationQiao-Zhu Zeng, Yuan-Yuan Zhang, Ye-Jun Wu, et al.
Current Medical Science|June 29, 2021
Predictive Value of Dynamic Peri-Transplantation MRD Assessed By MFC Either Alone or in Combination with Other Variables for Outcomes of Patients with T-Cell Acute Lymphoblastic LeukemiaZhi-Dong Wang, Yue-Wen Wang, Lan-Ping Xu, et al.
Pageof 111